21
Dec
2021
2021 CEO Year-End Letter
2021 CEO Year-End Letter English 2021 CEO Year-End Letter Swedish
News
20
Dec
2021
2021 ASH Annual Meeting – Posters
Treatment with an Allogeneic Leukemia-derived Dendritic Cell Vaccine in AML patients shows MRD conversion and improved survival van… Read more
11
Jun
2021
European Hematology Association (EHA) 2021 Virtual Meeting – Posters
Access the posters presented at the European Hematology Association (EHA) 2021 Virtual Meeting here: Leitch et al. –… Read more
8
Jun
2021
Immunicum Corporate Presentation at Redeye Growth Day 2021
On Wednesday, June 2nd, Erik Manting, CEO at Immunicum, presented a corporate overview at the Redeye Growth Day… Read more
19
Apr
2021
Immunicum Investor Event on April 22, 2021 at 1:00 pm CET
Immunicum will host an Investor Event on April 22, 2021 with introductions and updates by the Executive Management… Read more
8
Dec
2020
Virtual Investor Event Materials
Immunicum Virtual Investor Event – 9 December 2020 at 15.00 CET Webcast Link: https://bit.ly/36V9VAQ Virtual Investor Event Presentation:… Read more
19
Nov
2020
Transaction Webcast Presentation
Click here to access the transaction webcast presentation: Transaction Webcast Details
18
Nov
2020
Transaction Webcast Details
Representatives of Immunicum & DCprime will hold a live webcast on Thursday, November 19th at 8:00 a.m. CET… Read more
13
Oct
2020
Allogeneic inflammatory dendritic cells, Mimicking anti-viral innate immunity against cancer
Allogeneic inflammatory dendritic cells, Mimicking anti-viral innate immunity against cancer This article was published in the October 2020… Read more
17
Sep
2020
ESMO Virtual Congress 2020 Poster Presentation
Click here for access to the full poster presented at the ESMO Virtual Congress 2020: Full Poster
